trending Market Intelligence /marketintelligence/en/news-insights/trending/JDi5cVD1uQmSHiBagZqbdQ2 content esgSubNav
In This List

EyeGate prices $10M common stock, warrants offering

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


EyeGate prices $10M common stock, warrants offering

Eyegate Pharmaceuticals Inc. is looking to raise $10 million via a public offering.

The company will issue 6,666,667 shares at $1.50 apiece, complete with warrants to purchase an additional 6,666,667 stock within five years from the date of issue at the same price.

EyeGate plans to use the net proceeds for clinical trials, working capital and general corporate purposes.

Rodman & Renshaw is acting as the exclusive placement agent for the offering which is expected to close by June 14.